Cargando…
Similar Efficacy and Safety of Basaglar(®) and Lantus(®) in Patients with Type 2 Diabetes in Age Groups (< 65 Years, ≥ 65 Years): A Post Hoc Analysis from the ELEMENT-2 Study
INTRODUCTION: To compare efficacy and safety of Basaglar(®) [insulin glargine 100 units/mL; LY insulin glargine (LY IGlar)] to Lantus(®) [insulin glargine 100 units/mL; SA insulin glargine (SA IGlar)] in older (≥ 65 years) or younger (< 65 years) patients with type 2 diabetes (T2D). METHODS: This...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104266/ https://www.ncbi.nlm.nih.gov/pubmed/29542012 http://dx.doi.org/10.1007/s13300-018-0405-5 |